Patrocinado

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National
Postado
0
98
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Faça o login para curtir, compartilhar e comentar!
Pesquisar
Categorias
Leia mais
International
Why Iran 'cannot turn back time' on public hijab rule
Despite facing potential repercussions, Iranian women are increasingly defying mandatory hijab...
Por BharatUpdates 0 0
International
Japan invests big in LNG despite climate-friendly promises
Despite a G7 pledge, Japan remains a major public financier of oil and gas projects, investing...
Por BharatUpdates 0 0
Educação
Kerala DHSE Plus 2 results 2025 declared with 77.81% pass percentage: Girls outperform boys; Science stream records highest success
Por BharatUpdates 0 3
National
Janamat Party preparing to recall two ministers from Madesh Province govt
JANAKPURDHAM: The Janamat Party is preparing to recall two of its ministers currently serving in...
Por HamroGlobal 0 3
International
What is China's space mission Tianwen-2?
China's Tianwen-2 mission, set to launch in late May 2025, marks the nation's first endeavor to...
Por BharatUpdates 0 13
© 2025 Dununu.com : Circle of Life - Santan Social Network Portuguese (Brazil)
English नेपाली हिन्दी Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek Arabic French অসমীয়া বাংলা
DMCA Sobre Privacidade Termos Fale conosco Diretório